The leading industry event brings together experts, governments and around 2,200 exhibitors to discuss the issues facing the biotechnology sector and showcases the latest developments and products.
The UK's regulatory and ethical environment has already attracted top US and European stem cell researchers to Britain
Dr Mike Fisher
Life Sciences Industry Adviser
UKTI
During the event, UK Trade and Investment (UKTI) will draw attention to the UK’s thriving biotechnology and pharmaceutical industry, which undertakes 35 per cent of all European biopharmaceutical trials and has developed 15 of the world's 75 best selling drugs.
The sector invested £21 billion in research and development in 2007 and is the world's second largest drugs pipeline, topped only by the US.
UK Life Sciences opportunities
Find out more about the Life Sciences sector in the UK
UKTI will also host seminars on cutting-edge areas of the sector, including tackling diseases affecting the world's aging population and stem-cell research, with UK experts debating topics such as ethics and international competitiveness.
Dr Mike Fisher, UKTI life sciences Industry Adviser, praised the UK's commitment to supporting stem-cell developments.
Gov. Schwarzenegger at BIO
Watch a video of Gov. Schwarzenegger discussing biotechnology’s developments in R&D and praising the UK’s expertise.
"The UK's regulatory and ethical environment has already attracted top US and European stem cell researchers to Britain," he commented.
"Importantly, we are also seeing inward investment to support new projects - based on the UK's reputation as leading innovation in this field," Dr Fisher concluded.
Biotech is the leading industry event. This year it is hosted in California and runs from 17 to 20 June.
Printable Version
Email this page
Add to My UK